… The primary objective of this study was to compare overall survival (OS) of patients with
locally advanced bladder cancer postcystectomy treated with adjuvant chemotherapy with OS of …

… Radical cystectomy has been established as a gold standard for locally advanced bladder
cancer in the last two decades. Although only about 40% of patients survived at 5 years after …

… Physicians should consider postchemotherapy surgical resection of residual cancer in some
patients with locally advanced bladder cancer who would likely succumb to disease without …

… locally advanced bladder cancer who are candidates for radical cystectomy. A safe and
successful outcome with this four-drug regimen requires the selection of patients with adequate …

… Recent years have seen several advances in the treatment of locally advanced and metastatic
bladder cancer. We summarize the current state of the art for advanced bladder cancer …

… Patients with locally advanced bladder cancer at the time of … About a third will develop a
local-regional recurrence as the … for patients with locally advanced bladder cancer who did not …

The uroplakins are widely regarded as urothelium‐specific markers of terminal urothelial
cytodifferentiation. This study investigated the expression of the four uroplakin genes, UPIa, …

… in the pathogenesis of bladder cancer. While controversial, … ment and progression of bladder
cancer there exists a contin … in bladder cancer, we studied 34 primary bladder tumors by …

… Purpose: The standard of care for locally advanced bladder cancer (LABC) is neoadjuvant
chemotherapy followed by cystectomy. However, the role of adjuvant therapy is unclear. The …

… of Texas MD Anderson Cancer Center decided to include chemotherapy as part of the routine
care of patients with high-risk, locally advanced bladder cancer. The emerging data on the …